Cryoport Inc
$ 10.59
2.32%
20 Apr - close price
- Market Cap 530,230,000 USD
- Current Price $ 10.59
- High / Low $ 10.68 / 10.28
- Stock P/E N/A
- Book Value 9.23
- EPS -0.84
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.08 %
- 52 Week High 11.45
- 52 Week Low 5.31
About
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$13.61
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-03 | 2025-11-04 | 2025-08-12 | 2025-05-05 | 2025-03-10 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-12 | 2023-11-08 | 2023-08-09 | 2023-05-04 |
| Reported EPS | -0.1712 | -0.18 | -0.28 | -0.3836 | -0.4271 | -0.02 | -0.29 | -0.43 | -1.31 | -0.31 | -0.42 | -0.16 |
| Estimated EPS | -0.2139 | -0.24 | -0.27 | -0.2577 | -0.3064 | -0.29 | -0.39 | -0.35 | -0.29 | -0.3 | -0.24 | -0.19 |
| Surprise | 0.0427 | 0.06 | -0.01 | -0.1259 | -0.1207 | 0.27 | 0.1 | -0.08 | -1.02 | -0.01 | -0.18 | 0.03 |
| Surprise Percentage | 19.9626% | 25% | -3.7037% | -48.8553% | -39.393% | 93.1034% | 25.641% | -22.8571% | -351.7241% | -3.3333% | -75% | 15.7895% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CYRX
2026-04-20 19:39:22
Cryoport (NASDAQ: CYRX) announced it will report its first-quarter 2026 financial results on Monday, May 4, 2026, after U.S. markets close. Following the earnings release, a "Cryoport First Quarter 2026 in Review" document will be available at 4:05 p.m. ET, and management will host a Q&A conference call at 5:00 p.m. ET. The company will also provide a slide deck and webcast details for investors.
2026-04-18 07:39:33
Cryoport Inc. specializes in temperature-controlled logistics for sensitive biological materials, serving the rapidly growing cell and gene therapy (CGT) market. The company's core business model focuses on precision logistics for life sciences, leveraging specialized technology and a global network to ensure the integrity of high-value shipments. While facing risks like client concentration and capacity constraints, analysts generally maintain positive ratings, emphasizing Cryoport's leadership in CGT, recurring revenue, and long-term growth potential from the booming biotech sector.
2026-04-17 06:10:02
CryoPort, Inc. (NASDAQ:CYRX) has received a "Moderate Buy" consensus rating from nine analysts with an average 12-month price target of $13.31. The company recently missed quarterly EPS estimates but exceeded revenue expectations. Insider selling activity was noted, though institutional investors have adjusted their holdings, with 92.90% of the stock owned by institutions.
2026-04-16 18:14:00
This article analyzes Cryoport Inc. (NASDAQ: CYRX), indicating a strong sentiment across all time horizons and an overweight bias. It highlights a significant 53.0:1 risk-reward setup targeting a 16.0% gain. The piece also provides distinct institutional trading strategies tailored for different risk profiles, including position trading, momentum breakout, and risk hedging strategies.
2026-04-09 01:08:50
This article provides a detailed overview of CRYOPORT INC (NASDAQ:CYRX) stock, including its current price, performance metrics, key statistics, and technical and fundamental analysis ratings from ChartMill. It also covers recent earnings, analyst forecasts, financial highlights, ownership information, and a company profile outlining its logistics solutions for the life science industry.
2026-04-08 22:39:57
Cryoport (CYRX) President and CEO Jerrell Shelton exercised stock options for 50,000 shares at an exercise price of $1.87 per share. Following this transaction, he directly holds 1,126,607 shares of Cryoport common stock and 104,007 remaining options. The options exercised were part of a grant that vested monthly over 48 months starting May 6, 2016, and were set to expire on May 6, 2026.
